3 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 3 |
| Phase 2 | 1 | Recruiting 1 |
Follow Thyroid Eye Disease (TED): new trials by email Literature Review of Thyroid Eye Disease (TED) trials Research Report on Thyroid Eye Disease (TED)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease ETHY-001, Placebo - Thyroid Eye Disease (TED), Graves' Disease | Phase 1 | Recruiting | Ethyreal Bio, Inc. | 72 | 2026-07-06 | 2026-10-26 |
| A Study of VV-14305 for the Treatment of Thyroid Eye Disease VV-14305, Sham (No Treatment) - Thyroid Eye Disease (TED) | Phase 1 / Phase 2 | Recruiting | Kriya Therapeutics, Inc. | 135 | 2026-05-01 | 2026-08-27 |
| A Study of GenSci098 in Subjects With Active Thyroid Eye Disease GenSci098, GenSci098 Placebo - Safety, Tolerability | Phase 1 | Recruiting | Changchun GeneScience Pharmaceutical Co., Ltd. | 76 | 2024-09-24 | 2026-02-11 |
Graves Ophthalmopathy (3) · Autoimmune Diseases (1) · Endocrine System Diseases (1) · Exophthalmos (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Goiter (1) · Graves Disease (1) · Hyperthyroidism (1) · Immune System Diseases (1) · Orbital Diseases (1) · Thyroid Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3) · Autoimmune Diseases (2) · Endocrine System Diseases (2) · Exophthalmos (2) · Eye Diseases (2) · Eye Diseases, Hereditary (2) · Goiter (2) · Graves Disease (2) · Hyperthyroidism (2) · Immune System Diseases (2) · Orbital Diseases (2) · Thyroid Diseases (2)
Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Ethyreal Bio, Inc. (1) · Kriya Therapeutics, Inc. (1)
United States (2) · China (1) · New Zealand (1)